The White House Office of Science and Technology Policy (OSTP) has released a report examining the current state and potential expansion of the United States’ biomanufacturing sector as part of the evolving bioeconomy. This sector, which includes economic activities from biotechnology and biomanufacturing, is poised to significantly contribute to job creation and economic growth.
The report underscores recent advancements in biomanufacturing technology, particularly the programming of microbes to produce goods by manipulating their DNA. These developments enable the conversion of biological materials and waste into essential components for consumer products, pharmaceuticals, and fuels.
Recognizing the importance of biomanufacturing, the Biden-Harris Administration has issued an Executive Order aimed at enhancing this capacity across health, energy, agriculture, and industry sectors. The initiative calls for coordinated efforts across federal departments to develop strategies that will strengthen U.S. biomanufacturing.
Entitled “Building a Vibrant Domestic Biomanufacturing Ecosystem,” the report evaluates the U.S. landscape and identifies key growth drivers. Despite its leadership in biomanufacturing innovation, stakeholders have indicated a need for improved infrastructure to scale production domestically.
The report outlines 11 recommendations for policymakers to bolster U.S. biomanufacturing, aligning with the Biden-Harris Investing in America agenda, which focuses on climate goals, strengthening supply chains, and enhancing global competitiveness.
Key initiatives include the National Biotechnology and Biomanufacturing Initiative (NBBI), which coordinates federal research and promotes sustainable biomass production while streamlining biotechnology regulations.
Since the launch of the Bioeconomy Executive Order in 2022, federal investments in biomanufacturing have increased from $2.7 billion to over $3.5 billion, with substantial funding opportunities from federal agencies indicating strong government support.
The report advocates for continued collaboration among stakeholders to ensure ongoing progress in U.S. biotechnology and biomanufacturing innovation, aiming to solidify the nation’s standing in the global bioeconomy.
